MYC and small cell lung carcinoma: Hence, in neuroendocrine tumors loss of Mga/Max/PRC1.6 repressor function may be sufficient to bypass the requirement for Myc activity, as recently shown in Max-null human SCLC cell lines (Llabata et al, 2021).